Back to Market返回行情
MO
MOLN.SW Molecular Partners AG
SIXHealthcare$3.14+1.95%ClosedMarket Cap: $117.8M
As of 2026-05-29 11:31
Valuation
P/E (TTM)
-2.03
PEG
—
P/B
1.72
P/S
0.00
EV/EBITDA
-0.75
DCF Value
—
FCF Yield
-40.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-66.2%
ROA
-66.3%
ROIC
-69.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $0.00 | — | $-13.4M | $-13.1M | $-0.35 | — |
| Q4 2025 | $0.00 | — | $-12.7M | $-12.7M | $-0.34 | — |
| Q3 2025 | $0.00 | — | $-11.9M | $-11.8M | $-0.32 | — |
| Q2 2025 | $0.00 | — | $-17.3M | $-20.4M | $-0.55 | — |
| Q1 2025 | $0.00 | — | $-16.1M | $-16.8M | $-0.45 | — |
| Q4 2024 | $0.00 | — | $-14.8M | $-11.2M | $-0.30 | — |
| Q3 2024 | $681.0K | -1495.3% | $-14.6M | $-16.4M | $-0.49 | — |
| Q2 2024 | $1.6M | -743.8% | $-16.0M | $-15.1M | $-0.45 | — |
| Q1 2024 | $2.7M | -415.1% | $-15.9M | $-11.3M | $-0.34 | — |
| Q4 2023 | $1.0M | -1054.1% | $-16.6M | $-19.8M | $-0.60 | — |
| Q3 2023 | $2.5M | -356.8% | $-13.5M | $-11.4M | $-0.35 | — |
| Q2 2023 | $415.0K | -2702.9% | $-15.9M | $-16.0M | $-0.49 | — |